Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Haughney

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Trials|June 11, 2015
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trialGraham Devereux, Seonaidh Cotton, Peter Barnes, et al.
Health Technology Assessment (Winchester, England)|July 26, 2019
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCTGraham Devereux, Seonaidh Cotton, Shona Fielding, et al.
JAMA|October 17, 2018
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Shona Fielding, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2017
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma OutcomesDavid B Price, Miguel Román-Rodríguez, R Brett McQueen, et al.
Health Technology Assessment (Winchester, England)|May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCTGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Plos Pathogens|December 2, 2021
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccinationChris Davis, Nicola Logan, Grace Tyson, et al.
JAMA|May 19, 2024
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Plos One|January 8, 2025
Five year mortality in an RCT of a lung cancer biomarker to select people for low dose CT screeningFrancis Michael Sullivan, Frances S Mair, William Anderson, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 27, 2016
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care settingJanine A M Westerik, Victoria Carter, Henry Chrystyn, et al.
The European Respiratory Journal|August 1, 2020
Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imagingFrank M Sullivan, Frances S Mair, William Anderson, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Trials|June 11, 2015
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trialGraham Devereux, Seonaidh Cotton, Peter Barnes, et al.
Health Technology Assessment (Winchester, England)|July 26, 2019
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCTGraham Devereux, Seonaidh Cotton, Shona Fielding, et al.
JAMA|October 17, 2018
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Shona Fielding, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2017
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma OutcomesDavid B Price, Miguel Román-Rodríguez, R Brett McQueen, et al.
Health Technology Assessment (Winchester, England)|May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCTGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Plos Pathogens|December 2, 2021
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccinationChris Davis, Nicola Logan, Grace Tyson, et al.
JAMA|May 19, 2024
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Plos One|January 8, 2025
Five year mortality in an RCT of a lung cancer biomarker to select people for low dose CT screeningFrancis Michael Sullivan, Frances S Mair, William Anderson, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 27, 2016
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care settingJanine A M Westerik, Victoria Carter, Henry Chrystyn, et al.
The European Respiratory Journal|August 1, 2020
Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imagingFrank M Sullivan, Frances S Mair, William Anderson, et al.
Pageof 9